These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The effects of vasoactive intestinal polypeptide on the motility of human and guinea pig gallbladder. Feeley TM; Clanachan AS; Scott GW Can J Physiol Pharmacol; 1984 Apr; 62(4):356-9. PubMed ID: 6329495 [TBL] [Abstract][Full Text] [Related]
25. Vasoactive intestinal peptide in bovine pulmonary artery: localisation, function and receptor autoradiography. Barnes PJ; Cadieux A; Carstairs JR; Greenberg B; Polak JM; Rhoden K Br J Pharmacol; 1986 Sep; 89(1):157-62. PubMed ID: 3026543 [TBL] [Abstract][Full Text] [Related]
26. Relaxation of isolated bovine coronary arteries by vasoactive intestinal peptide. Itoh H; Lederis KP; Rorstad OP Eur J Pharmacol; 1990 Jun; 181(3):199-205. PubMed ID: 2384132 [TBL] [Abstract][Full Text] [Related]
27. Vasodilator action of guinea pig vasoactive intestinal polypeptide (VIP): comparison with common mammalian VIP. Naruse S; Inoue T; Mochizuki T; Yanaihara N Regul Pept; 1992 Dec; 42(3):163-71. PubMed ID: 1289976 [TBL] [Abstract][Full Text] [Related]
28. Dual actions of S-nitrosylated derivative of vasoactive intestinal peptide as a vasoactive intestinal peptide-like mediator and a nitric oxide carrier. Jia L; Stamler JS Eur J Pharmacol; 1999 Jan; 366(1):79-86. PubMed ID: 10064155 [TBL] [Abstract][Full Text] [Related]
29. Interaction of growth hormone-releasing factor (GRF) and 14 GRF analogs with vasoactive intestinal peptide (VIP) receptors of rat pancreas. Discovery of (N-Ac-Tyr1,D-Phe2)-GRF(1-29)-NH2 as a VIP antagonist. Waelbroeck M; Robberecht P; Coy DH; Camus JC; De Neef P; Christophe J Endocrinology; 1985 Jun; 116(6):2643-9. PubMed ID: 2859987 [TBL] [Abstract][Full Text] [Related]
30. Relaxant activity of atriopeptins in isolated guinea pig airway and vascular smooth muscle. O'Donnell M; Garippa R; Welton AF Peptides; 1985; 6(4):597-601. PubMed ID: 2933640 [TBL] [Abstract][Full Text] [Related]
31. Role of vasoactive intestinal polypeptide in the adaptation of intestinal smooth muscle cells to mechanical distension. Rekik M; Delvaux M; Frexinos J; Bueno L J Pharmacol Exp Ther; 1998 Dec; 287(3):832-8. PubMed ID: 9864261 [TBL] [Abstract][Full Text] [Related]
32. [Effect of vasoactive intestinal peptide on the motility of guinea-pig colon in vitro]. Ishizawa M Nihon Heikatsukin Gakkai Zasshi; 1988 Jun; 24(3):185-92. PubMed ID: 3246807 [TBL] [Abstract][Full Text] [Related]
33. Effect of vasoactive intestinal peptide (VIP) on the mechanical activity and [3H] acetylcholine release in guinea-pig gastric muscle. Milenov K; Kalfin R; Mandrek K Acta Physiol Pharmacol Bulg; 1991; 17(2-3):13-8. PubMed ID: 1819910 [TBL] [Abstract][Full Text] [Related]
34. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding. Zawilska JB; Dejda A; Niewiadomski P; Gozes I; Nowak JZ J Mol Neurosci; 2005; 25(3):215-24. PubMed ID: 15800375 [TBL] [Abstract][Full Text] [Related]
35. Vasoactive intestinal peptide as a possible transmitter of nonadrenergic, noncholinergic relaxation of pulmonary artery. Kubota E; Sata T; Soas AH; Paul S; Said SI Trans Assoc Am Physicians; 1985; 98():233-42. PubMed ID: 3842197 [TBL] [Abstract][Full Text] [Related]
36. Effects of vasoactive intestinal peptide, helodermin and galanin on responses of guinea-pig lung parenchyma to histamine, acetylcholine and leukotriene D4. Conroy DM; Samhoun MN; Piper PJ Br J Pharmacol; 1991 Dec; 104(4):1012-8. PubMed ID: 1725762 [TBL] [Abstract][Full Text] [Related]
37. Effects of avian pancreatic peptide on smooth muscle relaxations by vasoactive intestinal peptide and inhibitory nerve stimulation. Ito S; Ohta T; Nakazato Y; Ohga A; Yanaihara N Jpn J Pharmacol; 1986 Mar; 40(3):423-34. PubMed ID: 3712869 [TBL] [Abstract][Full Text] [Related]